Neuberger Berman Group LLC Repligen Corp Transaction History

Neuberger Berman Group LLC

$124 Billion
Q2 2025

A detailed history of Neuberger Berman Group LLC transactions in Repligen Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,211 shares of RGEN stock, worth $608,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,211

Previous 4,211 -0.0%

Holding current value

$608,784

Previous $523,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$108.89 - $145.23 $134,479 - $179,359	-1,235 Reduced 22.68%	4,211 $523,000
Q1 2025 May 13, 2025	BUY	$127.24 - $174.24 $692,949 - $948,911	5,446 New	5,446 $692,000
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $53,785 - $75,140	449 Added 13.03%	3,894 $579,000
Q1 2024 Nov 14, 2024	SELL	$170.78 - $208.42 $15.1 Million - $18.4 Million	-88,352 Reduced 96.25%	3,445 $633,000
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $588,337 - $718,006	3,445 New	3,445 $633,000
Q4 2023 Nov 14, 2024	BUY	$114.17 - $185.35 $10.5 Million - $17 Million	91,797 New	91,797 $16.5 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $2.55 Million - $4.14 Million	22,313 Added 32.11%	91,797 $16.5 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $275,617 - $350,548	1,986 Added 2.94%	69,484 $11 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $9.09 Million - $11.8 Million	65,687 Added 3627.11%	67,498 $9.55 Million
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $2,005 - $2,575	13 Added 0.72%	1,811 $304,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $10,394 - $14,115	-64 Reduced 3.44%	1,798 $304,000
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $34,490 - $55,085	215 Added 13.05%	1,862 $348,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $231,699 - $309,668	1,647 New	1,647 $267,000
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $6.85 Million - $11.4 Million	-35,172 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $688,194 - $916,721	-4,149 Reduced 10.55%	35,172 $6.96 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $2.2 Million - $2.76 Million	12,197 Added 44.97%	39,321 $7.6 Million
Q4 2020 Feb 10, 2021	BUY	$148.08 - $206.57 $591,727 - $825,453	3,996 Added 17.28%	27,124 $5.18 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $2,450 - $3,165	20 Added 0.09%	23,128 $3.41 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $185,547 - $276,324	-1,967 Reduced 7.84%	23,108 $2.84 Million
Q1 2020 May 14, 2020	SELL	$84.96 - $109.14 $1.73 Million - $2.22 Million	-20,325 Reduced 44.77%	25,075 $2.42 Million
Q3 2019 Nov 13, 2019	BUY	$76.65 - $95.51 $352,590 - $439,346	4,600 Added 11.27%	45,400 $3.48 Million
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $856,360 - $1.36 Million	15,800 Added 63.2%	40,800 $3.51 Million
Q1 2019 May 13, 2019	BUY	$49.45 - $62.8 $1.24 Million - $1.57 Million	25,000 New	25,000 $1.48 Million

Others Institutions Holding RGEN

# of Institutions

510

Shares Held

59M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Repligen Corp Transaction History